Y. Hori

发表

Decreased circulating levels of active ghrelin are associated with increased oxidative stress in obese subjects.

E. Gabazza, S. Murashima, K. Nakatani, 2005, European journal of endocrinology.

Oxidative stress is associated with adiposity and insulin resistance in men.

E. Gabazza, S. Murashima, K. Nakatani, 2003, The Journal of clinical endocrinology and metabolism.

Acute hyperinsulinemia is associated with increased circulating levels of adrenomedullin in patients with type 2 diabetes mellitus.

E. Gabazza, S. Murashima, K. Nakatani, 2002, European journal of endocrinology.

Neither homeostasis model assessment nor quantitative insulin sensitivity check index can predict insulin resistance in elderly patients with poorly controlled type 2 diabetes mellitus.

E. Gabazza, S. Murashima, K. Nakatani, 2002, The Journal of clinical endocrinology and metabolism.

Insulin resistance is associated with increased circulating level of thrombin-activatable fibrinolysis inhibitor in type 2 diabetic patients.

E. Gabazza, Koji Suzuki, Y. Adachi, 2002, The Journal of clinical endocrinology and metabolism.

Plasma levels of agouti-related protein are increased in obese men.

E. Gabazza, T. Tanaka, S. Murashima, 2001, The Journal of clinical endocrinology and metabolism.

Plasma levels of natriuretic peptides are correlated with renin activity in normotensive type 2 diabetic patients.

E. Gabazza, T. Tanaka, Y. Adachi, 2000, Diabetes care.

Elevated plasma levels of α-melanocyte stimulating hormone (α-MSH) are correlated with insulin resistance in obese men

K. Tsuchihashi, S. Murashima, Y. Adachi, 2000, International Journal of Obesity.

Insulin Sensitivity Is Not Affected by Mutation of Codon 972 of the Human IRS-1 Gene

K. Tsuchihashi, K Ito, Y. Adachi, 1999, Hormone Research in Paediatrics.

“Green juice”–associated granulomatous hepatitis

M. Kaito, M. Iwasa, Y. Adachi, 2003, American Journal of Gastroenterology.

Plasma brain natriuretic peptide levels in normotensive noninsulin-dependent diabetic patients with microalbuminuria.

E. Gabazza, K. Nakatani, Y. Adachi, 1999, The Journal of clinical endocrinology and metabolism.

Association between endothelial nitric oxide synthase Glu298Asp polymorphism and postchallenge insulin levels in nondiabetic Japanese subjects.

E. Gabazza, K. Nakatani, Y. Adachi, 2003, Diabetes care.

Increased plasma thrombin-activatable fibrinolysis inhibitor levels in normotensive type 2 diabetic patients with microalbuminuria.

E. Gabazza, K. Nakatani, O. Taguchi, 2003, The Journal of clinical endocrinology and metabolism.

Adiponectin gene variation associates with the increasing risk of type 2 diabetes in non-diabetic Japanese subjects.

J. Nishioka, K. Nakatani, T. Nobori, 2005, International journal of molecular medicine.

Nitric oxide stimulates glucose transport through insulin-independent GLUT4 translocation in 3T3-L1 adipocytes.

E. Gabazza, K. Nakatani, T. Nobori, 2003, European journal of endocrinology.

Troglitazone reduces plasma levels of tumour necrosis factor‐α in obese patients with type 2 diabetes

K. Tsuchihashi, K. Murata, E. Gabazza, 2000, Diabetes, obesity & metabolism.

Increased oxidative stress is associated with elevated plasma levels of adrenomedullin in hypertensive patients with type 2 diabetes.

E. Gabazza, K. Nakatani, Y. Adachi, 2003, Diabetes care.

Homeostasis model assessment is a reliable indicator of insulin resistance during follow-up of patients with type 2 diabetes.

E. Gabazza, S. Murashima, Y. Adachi, 2001, Diabetes care.

REVERSIBLE PERIPHERAL INSULIN RESISTANCE IN NON-OBESE PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES MELLITUS

K. Tsuchihashi, E. Gabazza, S. Murashima, 1999 .

Insulin enhanced thrombin-activable fibrinolysis inhibitor expression through PI3 kinase/Akt pathway.

E. Gabazza, K. Nakatani, T. Nobori, 2005, International journal of molecular medicine.

Relationship of the tumor necrosis factor-alpha -308 A/G promoter polymorphism with insulin sensitivity and abdominal fat distribution in Japanese patients with type 2 diabetes mellitus.

E. Gabazza, Y. Adachi, Y. Yano, 2002, Diabetes research and clinical practice.

Troglitazone improves GLUT4 expression in adipose tissue in an animal model of obese type 2 diabetes mellitus.

E. Gabazza, K. Nakatani, Y. Adachi, 2002, Diabetes research and clinical practice.

Association between plasma thrombin-activatable fibrinolysis inhibitor levels and activated protein C in normotensive type 2 diabetic patients.

E. Gabazza, Y. Adachi, Y. Yano, 2002, Diabetes care.

ISPAD 2001: 1st Announcement

C. Christoffersen, H. Vestergaard, L. Baur, 1999, Hormone Research in Paediatrics.

35th Annual meeting of the European Association for the Study of Diabetes. Brussels, Belgium, 28 September-2 October, 1999. Abstracts.

Thomas J. Smith, B. M. Rasmussen, V. C. Phan, 1999, Diabetologia.

Different metabolic correlations of thrombin-activatable fibrinolysis inhibitor and plasminogen activator inhibitor-1 in non-obese type 2 diabetic patients.

N. Bruno, E. Gabazza, Koji Suzuki, 2006, Diabetes research and clinical practice.

QUICKI is useful for following improvements in insulin sensitivity after therapy in patients with type 2 diabetes mellitus.

E. Gabazza, S. Murashima, K. Nakatani, 2002, The Journal of clinical endocrinology and metabolism.

Metformin-induced suppression of glucose-6-phosphatase expression is independent of insulin signaling in rat hepatoma cells.

J. Nishioka, E. Gabazza, K. Nakatani, 2005, International journal of molecular medicine.